FDA Inspection
Braintree, A part of SEBELA PharmaceuticalsBraintree, A part of SEBELA Pharmaceuticals – FDA Inspection, Jan 22, 2010
Record Details
This FDA Inspection record concerns Braintree, A part of SEBELA Pharmaceuticals, with an inspection on January 22, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 22, 2010
- Product Type
- Drugs
View Company Profile
ID · d29d717b-48d5-4e5e-bee4-6184a59792c0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 639857
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Braintree, A part of SEBELA Pharmaceuticals
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 14, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Braintree, A part of SEBELA Pharmaceuticals
- FDA Inspection 1261728 - 2025-03-07
- FDA Inspection 1042622 - 2018-02-28
- FDA Inspection 858979 - 2013-12-13
- FDA Inspection 814842 - 2013-01-14
- FDA Inspection 707123 - 2011-01-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.